These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35349635)

  • 1. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
    Lee TH; Hunt CM; Maier MM; Lowy E; Beste LA
    Clin Infect Dis; 2022 Oct; 75(9):1529-1536. PubMed ID: 35349635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care quality and outcomes among US veterans with chronic hepatitis B in the hepatitis C direct-acting antiviral era.
    Kaplan DE; Medvedeva E; Serper M
    J Viral Hepat; 2020 Oct; 27(10):1082-1092. PubMed ID: 32484991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
    Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
    Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple Threat: HDV, HBV, HIV Coinfection.
    Yen DW; Soriano V; Barreiro P; Sherman KE
    Clin Liver Dis; 2023 Nov; 27(4):955-972. PubMed ID: 37778779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
    Surial B; Ramírez Mena A; Roumet M; Limacher A; Smit C; Leleux O; Mocroft A; van der Valk M; Bonnet F; Peters L; Rockstroh JK; Günthard HF; Berzigotti A; Rauch A; Wandeler G; ; ; ;
    J Hepatol; 2023 May; 78(5):947-957. PubMed ID: 36690280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of Antiviral Therapy for Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Nationwide Real-World US Study.
    Kudaravalli S; Kam LY; Huang DQ; Cheung R; Nguyen MH
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3305-3313.e4. PubMed ID: 37805836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing and improving the quality of guideline-adherent hepatitis B virus care in people with HIV: A cross-sectional study.
    Oomen PG; van Kraaij VJ; Gerritsma AM; Verduyn Lunel FM; Boland GJ; Hoepelman AI; van Welzen BJ
    Int J STD AIDS; 2024 Oct; 35(11):910-915. PubMed ID: 37728881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study.
    Riebensahm C; Chitundu H; Muula G; Chihota B; Sinkala E; Sunkutu V; Maurer MH; Dufour JF; Berzigotti A; Egger M; Bolton-Moore C; Vinikoor M; Wandeler G;
    Int J Infect Dis; 2022 Mar; 116():391-396. PubMed ID: 34952210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
    Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
    J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
    Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
    Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.
    Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G
    Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis B.
    Patel N; Post FA
    Int J STD AIDS; 2022 Feb; 33(2):202-204. PubMed ID: 34546112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
    Ferrante ND; Lo Re V
    Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
    Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
    Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia.
    Muula GK; Bosomprah S; Sinkala E; Nsokolo B; Musonda T; Hamusonde K; Bhattacharya D; Lauer G; Chung RT; Mulenga LB; Wandeler G; Vinikoor MJ
    AIDS; 2023 Nov; 37(13):2015-2020. PubMed ID: 37467044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort.
    Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
    Clin Infect Dis; 2022 Mar; 74(6):1012-1021. PubMed ID: 34197574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.